32
TRISOMY 21- DOWN TRISOMY 21- DOWN SYNDROME SYNDROME Dr. Gupta PL-II

trisomy21.ppt

Embed Size (px)

Citation preview

Page 1: trisomy21.ppt

TRISOMY 21- TRISOMY 21- DOWN SYNDROMEDOWN SYNDROME

Dr. Gupta

PL-II

Page 2: trisomy21.ppt

IncidenceIncidence

Approximately one in 1000 live births.

Page 3: trisomy21.ppt

Genetics

Trisomy 21 (47, +21), - 94 %, The frequency of trisomy increases with increasing maternal age.

Robertsonian translocation involving chromosome 21- Approx. 3-4 %, not related to maternal age.

Trisomy 21 mosaicism – 2 to 3 % cases

Page 4: trisomy21.ppt
Page 5: trisomy21.ppt
Page 6: trisomy21.ppt
Page 7: trisomy21.ppt
Page 8: trisomy21.ppt

Clinical Features

Head and neck Brachycephaly Up-slanting palpebral fissures Epicanthal folds Brushfield spots Flat nasal bridge Folded or dysplastic ears Open mouth Protruding tongue Short neck Excessive skin at the nape of

neck

Extremities Short broad hands Short fifth finger Incurved fifth finger Transverse palmer crease Space between first and second

toe Hyper flexibility of joints

Page 9: trisomy21.ppt
Page 10: trisomy21.ppt
Page 11: trisomy21.ppt

Neonatal features

Flat facial profile Poor Moro reflex Excessive skin at the

nape of neck Slanted palpebral

fissures Hypotonia Hyper flexibility of

joints

Dysplasia of pelvis Anomalous ears Dysplasia of

midphalanx of fifth finger

Transverse palmer crease

Page 12: trisomy21.ppt
Page 13: trisomy21.ppt

Mental Retardation

Almost all DS babies have MR. Mildly to moderately retarded . Starts in the first year of life. Average age of sitting(11 mon), and walking (26

mon) is twice the typical age. First words at 18 months. IQ declines through the first 10 years of age,

reaching a plateau in adolescence that continues into adulthood.

Page 14: trisomy21.ppt

Heart Disease

50 % of Down Syndrome pts have heart disease Atrioventricular septal defect VSD Secundum ASD PDA Tetrology of Fallot Mitral valve prolapse AR, MR

Page 15: trisomy21.ppt

GI abnormalities

5% of cases Duodenal atresia or stenosis, sometimes assoc with

annular pancreas in 2.5 % of cases Imperforate anus Esophageal atresia with TE fistula is less common Hirschsprung’s disease Strong assoc with celiac disease b/w 5 – 16 % , 5

– 16 fold increase as compared to general population

Page 16: trisomy21.ppt

Growth

BW, length and HC are less in DS Reduced growth rate Prevalence of obesity is greater in DS Weight is less than expected for length in

infants with DS, and then increases disproportion ally so that they are obese by age 3-4 yrs

Page 17: trisomy21.ppt
Page 18: trisomy21.ppt

Eye problems

Most common disorders are

Refractory error – 35 to 76 percent

Strabismus – 25 to 57 percent

Nystagmus – 18 to 22 percent

Cataract occur in 5 % of newborns.

Frequency increases with age.

Page 19: trisomy21.ppt

Hearing loss

Unilateral or bilateral Conductive, sensorineural or mixed Otitis media is a frequent problem

Page 20: trisomy21.ppt

Hematologic disorders

The risk of leukemia is 1 to 1.5 percent. 65% of newborn have polycythemia resulting in

hypoglycemia. Risk of AML and ALL is also much higher than the

general population. Transient leukemia – exclusively affects NB. - It is asymptomatic with spontaneous resolution in 2-3

months. - Vesiculopustular skin eruptions are common and

resolve with disorder.

Page 21: trisomy21.ppt

Endocrine disorder

Thyroid disease – Hypothyroidism occurs more frequently than hyperthyroidism.

Diabetes – The risk of type 1 diabetes is three times greater than that of the general population.

Page 22: trisomy21.ppt

Reproduction

Women with DS are fertile and may become pregnant.

Nearly all males with DS are infertile. The mechanism is impairment of spermatogenesis

Page 23: trisomy21.ppt

Atlantoaxial instability

Excessive mobility of atlas (C1) and the axis (C2), may lead to subluxation of the cervical spine.

Diagnosis made by lateral neck radiograph. Patients are advised to avoid contact

sports.

Page 24: trisomy21.ppt

Sleep apnea

Obstructive sleep apnea is more common.

Page 25: trisomy21.ppt

Skin disorder

Palmoplantar hyperkeratosis Seborreic dermatitis Fissured tongue Cutis marmorata Geographical tongue Xerosis

Page 26: trisomy21.ppt

Diagnosis

Prenatal screening If no screening – It is recognized from the

characteristic phenotypic features. Confirmed by Karyotype.

Page 27: trisomy21.ppt

Management

1. Growth – Measurements should be plotted on the appropriate growth chart for children with DS.

This will help in prevention of obesity and early diagnosis of celiac disease and hypothyroidism.

2. Cardiac disease – All newborns should be evaluated by cardiac ECHO for CHD in consultation with pediatric cardiologist.

3. Hearing – Screening to be done in the newborn period, every 6 months until 3 yrs of age and then annually.

Page 28: trisomy21.ppt

Management (cont.)4. Eye disorders - An eye exam should be

performed in the newborn period or at least before 6 months of age to detect strabismus, nystagmus, and cataracts.

5. Thyroid Function – Should be done in newborn period and should be repeated at six and 12 months , and then annually.

6. Celiac Disease – Screening should begin at 2 yrs. Repeat screening if signs/Sx develop.

Page 29: trisomy21.ppt

Management ( cont)7. Hematology – CBC with differential at birth to

evaluate for polycythemia as well as WBC.

8. Atlanto-axial instability – X ray for evidence of AAI or sub-luxation at 3 to 5 years of age.

9. Alzheimer’s disease – Adult with a Down Syndrome has earlier onset of symptoms. When diagnosis is considered, thyroid disease and possible depression should be excluded.

Page 30: trisomy21.ppt

MortalityMedian age of death has increased from 25 yrs in 1983 to 49 yrs in 1997, an average of 1.7 yrs increase per year.

Most likely cause of death is CHD, Dementia, Hypothyroidism and Leukemia.

Improved survival is because of increased placements of infants in homes andchanges in treatment for common causes of death.

Survival is better for males and blacks.

Page 31: trisomy21.ppt

Counseling

May begin when a prenatal diagnosis is made. Discuss the wide range of variability in

manifestation and prognosis. Medical and educational treatments and

interventions should be discussed. Initial referrals for early intervention, informative

publications, parent groups, and advocacy groups.

Page 32: trisomy21.ppt